Did You Know
Ozempic (semaglutide) is more effective than dulaglutide (Trulicity)
Author contributions AFW: Conceptualization, Methodology, Software, Formal Analysis, Investigation, Visualization, Data curation, Writing original draft, Writing review and editing
MS-based proteomic analyses were performed by the Proteomics Core Facility, Department of Immunology, University of Oslo/Oslo University Hospital, which is supported by the Core Facilities program of the South-Eastern Norway Regional Health Authority
The Medicines and Healthcare products Regulatory Agency (MHRA) and the European Medicines Agency (EMA) continuously monitor the safety profile of semaglutide products
In various healthcare settings, acute kidney disease (AKD) has seen a rising incidence, with associated heightened risks of all-cause mortality, end-stage kidney disease, and chronic kidney disease (CKD)